Exploring tissue-based biomarkers is a crucial component of pre-clinical/clinical drug development, as it can help identify new therapeutic targets, evaluate surrogate markers of drug effectiveness, and predict potential benefits of a candidate compound.
Using image analysis allows us to evaluate tissue biomarkers in greater detail and study cellular interactions in complex biological processes. Our digital pathology data analysis workflow allows the automation of cell segmentation and their classification to resolve the molecular architecture of the tissue.
Download our application note to learn more: